Alkermes (ALKS) grants CFO Reed new stock options and RSUs

Rhea-AI Filing Summary

Reed Joshua reported acquisition or exercise transactions in this Form 4 filing.

Alkermes plc reported that its Senior Vice President and Chief Financial Officer, Joshua Reed, received new equity awards. On March 2, 2026, he was granted 66,430 employee stock options and 30,854 restricted stock units, each RSU representing one ordinary share.

The stock options and RSUs vest in four equal annual installments starting on March 2, 2027, meaning the awards will fully vest over four years if service-based conditions are met. These are non-cash compensation grants and do not represent open-market purchases or sales of Alkermes shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reed Joshua

(Last) (First) (Middle)

900 WINTER STREET

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$30.25	03/02/2026		A		66,430		(1)	03/02/2036	Ordinary Shares	66,430	$0	66,430	D
Restricted Stock Unit Award	(2)	03/02/2026		A		30,854		(3)	(3)	Ordinary Shares	30,854	$0	30,854	D

Explanation of Responses:

1. Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027.

2. Each restricted stock unit represents a contingent right to receive one ordinary share.

3. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027.

	/s/ Shantale Greenson, attorney-in-fact for Joshua Reed	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Alkermes (ALKS) report for CFO Joshua Reed?

Alkermes reported that CFO Joshua Reed received equity awards, not open-market trades. He was granted 66,430 employee stock options and 30,854 restricted stock units as part of his compensation on March 2, 2026, all held directly.

How many stock options were granted to Alkermes CFO Joshua Reed?

Joshua Reed was granted 66,430 employee stock options. These options vest and become exercisable in four equal annual installments beginning March 2, 2027, spreading the potential ownership benefit over four years, subject to continued service and the award’s terms.

What are the details of the restricted stock units granted to Alkermes CFO?

Reed received 30,854 restricted stock units, each representing a contingent right to one ordinary share of Alkermes. The RSUs vest in four equal annual installments starting March 2, 2027, aligning long-term incentives with the company’s performance and his continued employment.

Do the Alkermes CFO’s new equity awards involve any purchase price?

The Form 4 shows a transaction price per share of 0.0000 for both the options and RSUs. This indicates they were granted as compensation rather than purchased in the market, with future value depending on vesting and Alkermes’ share performance.

When do Joshua Reed’s Alkermes stock options and RSUs start vesting?

Both the stock options and restricted stock units begin vesting on March 2, 2027. Vesting occurs in four equal annual installments from that date, so the full awards will vest over a four-year period, assuming conditions in the award agreements are satisfied.